151910 — SBW Life Sciences Co Cashflow Statement
0.000.00%
Last trade - 00:00TechnologyHighly SpeculativeSmall Cap
- KR₩122bn
- KR₩132bn
- KR₩48bn
Annual cashflow statement for SBW Life Sciences Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -16,288 | -1,769 | -27,547 | -15,912 | -7,664 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 2,458 | 1,926 | 29,837 | 15,676 | 7,610 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1,959 | 248 | -3,030 | 2,310 | -3,822 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -7,882 | 6,211 | 5,069 | 6,671 | -510 |
| Capital Expenditures | -8,614 | -8,081 | -4,513 | -1,724 | -3,455 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -6,743 | 6,145 | -6,390 | -12,105 | -5,809 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -15,356 | -1,936 | -10,902 | -13,829 | -9,264 |
| Financing Cash Flow Items | 1 | — | — | 0 | 1,650 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 17,231 | 4,143 | 32,753 | -292 | -3,918 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -5,920 | 8,140 | 27,686 | -6,862 | -12,180 |